234 related articles for article (PubMed ID: 21028798)
1. Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.
Zhou H; Yu W; Guo X; Liu X; Li N; Zhang Y; Ma X
Biomacromolecules; 2010 Dec; 11(12):3480-6. PubMed ID: 21028798
[TBL] [Abstract][Full Text] [Related]
2. pH-sensitive chitosan-derived nanoparticles as doxorubicin carriers for effective anti-tumor activity: preparation and in vitro evaluation.
Jin YH; Hu HY; Qiao MX; Zhu J; Qi JW; Hu CJ; Zhang Q; Chen DW
Colloids Surf B Biointerfaces; 2012 Jun; 94():184-91. PubMed ID: 22405470
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin release from self-assembled nanoparticles of deoxycholic acid-conjugated dextran.
Jeong YI; Chung KD; Choi KC
Arch Pharm Res; 2011 Jan; 34(1):159-67. PubMed ID: 21468928
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of amphiphilic chitosan derivatives as a nano-carrier for paclitaxel delivery.
Zhou H; Liu X; Guo X; Li N; Yu W; Zhang Y; Ma X
J Control Release; 2011 Nov; 152 Suppl 1():e124-5. PubMed ID: 22195795
[No Abstract] [Full Text] [Related]
5. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
Hu FQ; Liu LN; Du YZ; Yuan H
Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
[TBL] [Abstract][Full Text] [Related]
7. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
Zhang J; Chen XG; Sun GZ; Huang L; Cheng XJ
Colloids Surf B Biointerfaces; 2010 Jun; 77(2):125-30. PubMed ID: 20172698
[TBL] [Abstract][Full Text] [Related]
8. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Zhang J; Chen XG; Li YY; Liu CS
Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
[TBL] [Abstract][Full Text] [Related]
9. Cationic nanoparticles self-assembled from amphiphilic chitosan derivatives containing poly(amidoamine) dendrons and deoxycholic acid as a vector for co-delivery of doxorubicin and gene.
Chen S; Deng J; Zhang LM
Carbohydr Polym; 2021 Apr; 258():117706. PubMed ID: 33593576
[TBL] [Abstract][Full Text] [Related]
10. Self-aggregated nanoparticles of carboxylic curdlan-deoxycholic acid conjugates as a carrier of doxorubicin.
Yan JK; Ma HL; Chen X; Pei JJ; Wang ZB; Wu JY
Int J Biol Macromol; 2015 Jan; 72():333-40. PubMed ID: 25193095
[TBL] [Abstract][Full Text] [Related]
11. Preparation of Cationic Amphiphilic Nanoparticles with Modified Chitosan Derivatives for Doxorubicin Delivery.
Liu X; Zhou H; Yu W; Xiong X; Krastev R; Ma X
Materials (Basel); 2021 Nov; 14(22):. PubMed ID: 34832408
[TBL] [Abstract][Full Text] [Related]
12. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
[TBL] [Abstract][Full Text] [Related]
13. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C
Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin.
Shi Z; Guo R; Li W; Zhang Y; Xue W; Tang Y; Zhang Y
J Mater Sci Mater Med; 2014 Mar; 25(3):723-31. PubMed ID: 24327111
[TBL] [Abstract][Full Text] [Related]
16. Stearic acid-g-chitosan polymeric micelle for oral drug delivery: in vitro transport and in vivo absorption.
Yuan H; Lu LJ; Du YZ; Hu FQ
Mol Pharm; 2011 Feb; 8(1):225-38. PubMed ID: 21138243
[TBL] [Abstract][Full Text] [Related]
17. Self-assemblied nanocomplexes based on biomimetic amphiphilic chitosan derivatives for protein delivery.
Wu M; Dong H; Guo K; Zeng R; Tu M; Zhao J
Carbohydr Polym; 2015 May; 121():115-21. PubMed ID: 25659679
[TBL] [Abstract][Full Text] [Related]
18.
Sun R; Fang L; Lv X; Fang J; Wang Y; Chen D; Wang L; Chen J; Qi Y; Tang Z; Zhang J; Tian Y
Drug Deliv; 2021 Dec; 28(1):2071-2084. PubMed ID: 34595970
[TBL] [Abstract][Full Text] [Related]
19. pH-responsive mechanism of a deoxycholic acid and folate comodified chitosan micelle under cancerous environment.
Chen D; Song P; Jiang F; Meng X; Sui W; Shu C; Wan LJ
J Phys Chem B; 2013 Feb; 117(5):1261-8. PubMed ID: 23311609
[TBL] [Abstract][Full Text] [Related]
20. Self-aggregated nanoparticles from linoleic acid modified carboxymethyl chitosan: Synthesis, characterization and application in vitro.
Tan YL; Liu CG
Colloids Surf B Biointerfaces; 2009 Mar; 69(2):178-82. PubMed ID: 19124228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]